0228-2571
Generic: indapamide
Labeler: actavis pharma, inc.Drug Facts
Product Profile
Brand Name
Generic Name
indapamide
Labeler
actavis pharma, inc.
Dosage Form
TABLET, FILM COATED
Active Ingredients
indapamide 2.5 mg/1
Identifiers & Regulatory
Product NDC
0228-2571
Product ID
0228-2571_38768262-8325-4d8f-ba11-dd7cf18a9e45
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
Listing Expiration
2026-12-31
Marketing Start
2023-05-16
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
02282571
Hyphenated Format
0228-2571
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
indapamide (source: label)
Generic Name
indapamide (source: ndc)
Application Number
ANDA074722 (source: label)
Routes
source: label
Resolved Composition
Strengths
- 2.5 mg/1
Packaging
- 68670 TABLET, FILM COATED in 1 BOX (0228-2571-00)
- 82404 TABLET, FILM COATED in 1 CONTAINER (0228-2571-77)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "38768262-8325-4d8f-ba11-dd7cf18a9e45", "openfda": {}, "finished": false, "packaging": [{"description": "68670 TABLET, FILM COATED in 1 BOX (0228-2571-00)", "package_ndc": "0228-2571-00", "marketing_start_date": "16-MAY-23"}, {"description": "82404 TABLET, FILM COATED in 1 CONTAINER (0228-2571-77)", "package_ndc": "0228-2571-77", "marketing_start_date": "22-AUG-24"}], "product_id": "0228-2571_38768262-8325-4d8f-ba11-dd7cf18a9e45", "dosage_form": "TABLET, FILM COATED", "product_ndc": "0228-2571", "generic_name": "Indapamide", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "INDAPAMIDE", "strength": "2.5 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20230516", "listing_expiration_date": "20261231"}